StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Schrödinger, Inc.
NasdaqGS:SDGR
Sector
Location
Market Cap
USD 1.59 B
Share Price
USD 21.01
Avg Daily Volume
1,308,276
Change (1 day)
-3.22%
Change (1 year)
-2.55%
Change (YTD)
8.92%
Schrödinger, Inc. Accounts Payable for the year ending December 31, 2024: USD 10.67 M
Schrödinger, Inc. Accounts Payable is USD 10.67 M for the year ending December 31, 2024, a -36.57% change year over year. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.
-
Schrödinger, Inc. Accounts Payable for the year ending December 31, 2023 was USD 16.82 M, a 77.56% change year over year.
-
Schrödinger, Inc. Accounts Payable for the year ending December 31, 2022 was USD 9.47 M, a 17.22% change year over year.
-
Schrödinger, Inc. Accounts Payable for the year ending December 31, 2021 was USD 8.08 M, a -3.80% change year over year.
-
Schrödinger, Inc. Accounts Payable for the year ending December 31, 2020 was USD 8.40 M, a 138.31% change year over year.
Competitors
Natera, Inc.
USD 160.43
NTRA
-2.93
-1.79%
Illumina, Inc.
USD 99.25
ILMN
-0.80
-0.80%
Tempus AI, Inc.
USD 56.88
TEM
-2.72
-4.56%
Veracyte, Inc.
USD 27.08
VCYT
-0.44
-1.60%
Azenta, Inc.
USD 33.47
AZTA
-0.68
-1.99%
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Novo Nordisk A/S
USD 68.61
NOVO-B.CO
-2.69
-3.77%
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
Novartis AG
USD 120.78
NOVN.SW
-3.44
-2.77%
Abbott Laboratories
USD 132.02
ABT
-1.58
-1.18%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Thermo Fisher Scientific Inc.
USD 434.86
TMO
+4.13
0.96%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Boston Scientific Corporation
USD 103.20
BSX
-0.66
-0.64%
Pfizer Inc.
USD 25.65
PFE
-0.13
-0.50%
Gilead Sciences, Inc.
USD 109.64
GILD
-4.90
-4.28%
Vertex Pharmaceuticals Incorporated
USD 468.85
VRTX
-10.68
-2.23%
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%
RELX Plc
USD 53.73
REL.L
-0.46
-0.84%
Key Data
| Date | Accounts Payable | Short-Term Debt | Long-Term Debt | Total Liabilities |
|---|
Competitors
Natera, Inc.
USD 160.43
NTRA
-2.93
-1.79%
Illumina, Inc.
USD 99.25
ILMN
-0.80
-0.80%
Tempus AI, Inc.
USD 56.88
TEM
-2.72
-4.56%
Veracyte, Inc.
USD 27.08
VCYT
-0.44
-1.60%
Azenta, Inc.
USD 33.47
AZTA
-0.68
-1.99%
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Novo Nordisk A/S
USD 68.61
NOVO-B.CO
-2.69
-3.77%
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
Novartis AG
USD 120.78
NOVN.SW
-3.44
-2.77%
Abbott Laboratories
USD 132.02
ABT
-1.58
-1.18%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Thermo Fisher Scientific Inc.
USD 434.86
TMO
+4.13
0.96%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Boston Scientific Corporation
USD 103.20
BSX
-0.66
-0.64%
Pfizer Inc.
USD 25.65
PFE
-0.13
-0.50%
Gilead Sciences, Inc.
USD 109.64
GILD
-4.90
-4.28%
Vertex Pharmaceuticals Incorporated
USD 468.85
VRTX
-10.68
-2.23%
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%
RELX Plc
USD 53.73
REL.L
-0.46
-0.84%